Cryptogenic cirrhosis in the region where obesity is not prevalent

doi:10.3748/wjg.v12.i13.2080

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 12, Issue 13

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (6239)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-2) series, Tables (1-3) series.

Item

Count

PDF

415

HTML

5453

Figures (1-2)

178

Tables (1-3)

193

Sum=6239

Apr 7, 2006 (publication date) through Nov 23, 2024

Times Cited of This Article

Times Cited (24)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Rapid Communication

World J Gastroenterol. Apr 7, 2006; 12(13): 2080-2085
Published online Apr 7, 2006. doi: 10.3748/wjg.v12.i13.2080

Table 1 Characteristics of cryptogenic cirrhotic patients and matched controls

	Cryptogenic(n=24)	Control; all(n=72)	HCV-related(n=48)	HBV-related(n=24)
Age (yr)	58.2 ± 10.6	58.6 ± 8.8	58.7 ± 8.1	58.3 ± 10.2
Child-Pugh score	6.3 ± 1.4	6.5 ± 1.2	6.5 ± 1.2	6.4 ± 1.3
Follow-up (yr)	5.7 ± 4.2	5.9 ± 4.4	6.5 ± 4.2	4.7 ± 4.5
Transfusion (%)	0	26.8 ^b	34.0 ^b	12.5
Body mass index (kg/m²)	25.5 ± 3.2	22.4 ± 3.0 ^b	22.6 ± 3.3 ^b	22.0 ± 2.4 ^b
ICGR15 (%)	31.5 ± 16.7	27.2 ± 12.3	28.2 ± 12.1	25.0 ± 12.7
Total bilirubin (mmol/L)	22 ± 15	21 ± 10	22 ± 10	19 ± 10
AST (nkat/L)	959 ± 572	1349 ± 772 ^a	1410 ± 573 ^b	1229 ± 1064
ALT (nkat/L)	860 ± 640	1229 ± 765 ^a	1359 ± 748 ^b	972 ± 747
AKP (nkat/L)	6518 ± 2942	6638 ± 2976	6695 ± 2577	6529 ± 3692
Albumin (g/L)	40 ± 5	38 ± 5	38 ± 5 ^b	38 ± 6
γ-globulin (g/L)	17 ± 3	18 ± 5	19 ± 4	15 ± 5
Cholinesterase (U/L)	242.8 ± 118.2	174.5 ± 67.8 ^b	162.1 ± 61.7 ^b	198.8 ± 73.7
Total cholesterol (mg/dL)	170.5 ± 43.0	156.5 ± 35.1	151.2 ± 31.3 ^b	166.8 ± 40.2
Triglyceride (mg/dL)	103.8 ± 44.2	83.0 ± 25.5 ^b	84.5 ± 26.6 ^b	80.1 ± 23.8 ^b
Prothrombin time (INR)	1.15 ± 0.15	1.19 ± 0.14	1.21 ± 0.14	1.16 ± 0.14
Hemoglobin A1c (%)	6.2 ± 1.3	5.1 ± 0.8 ^b	5.3 ± 0.9 ^a	4.8 ± 0.7 ^b
Blood glucose (mg/dL)	123.1 ± 48.2	96.4 ± 21.0 ^b	96.9 ± 23.0 ^b	95.2 ± 16.3 ^a
Insulin (mU/L)	26.8 ± 15.7	14.2 ± 6.4 ^b	15.9 ± 6.6 ^b	10.8 ± 4.5 ^b
HOMA-R (%)	8.6 ± 4.8	3.6 ± 2.5 ^b	4.0 ± 2.9 ^b	2.6 ± 1.3 ^b
QUICKI	0.29 ± 0.02	0.33 ± 0.03 ^b	0.32 ± 0.02 ^b	0.34 ± 0.04 ^b
Transferrin saturation (%)	36.3 ± 17.5	45.2 ± 29.7	48.5 ± 31.1	40.0 ± 27.8
Ferritin (mg/L)	160.0 ± 155.3	193.5 ± 282.9	225.0 ± 318.1	99.3 ± 104.8
Visceral fat area (cm²)	102.0 ± 39.8	56.9 ± 35.3 ^b	52.1 ± 30.7 ^a	64.3 ± 43.9 ^b
Liver/spleen ratio	1.08 ± 0.05	1.08 ± 0.06	1.07 ± 0.06	1.09 ± 0.06

^aP < 0.05, ^bP < 0.01 vs cryptogenic cirrhosis. ICGR15:indocyanine green retention rate, INR:international normalized ratio, HOMA-R:homeostasis model assessment parameter of insulin resistance, QUICKI: quantitative insulin check index.

Citation: Kojima H, Sakurai S, Matsumura M, Umemoto N, Uemura M, Morimoto H, Tamagawa Y, Fukui H. Cryptogenic cirrhosis in the region where obesity is not prevalent. World J Gastroenterol 2006; 12(13): 2080-2085
URL: https://www.wjgnet.com/1007-9327/full/v12/i13/2080.htm
DOI: https://dx.doi.org/10.3748/wjg.v12.i13.2080